A new trial suggests the optimal approach for basilar artery occlusion stroke may vary depending on whether the blockage ...

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and ...

More than 70% of people over 70 years old will one day develop cardiovascular disease, highlighting the need for effective ...

An international team mapped over 17,000 genetic variants in the LDLR gene, which helps clear “bad” cholesterol from the ...

Building on earlier studies showing its benefits for type 2 diabetes, a new study has revealed the experimental drug IC7Fc ...

Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have shown that 18 FDG-PET, an imaging technique widely used to study other conditions, can also be used to monitor ...

Oral presentation name: Enobosarm in Combination With GLP-1RA is Selective for Fat Loss While Preserving Lean and Function ...

The Family Heart Foundation, the leading research, education and advocacy organization focused on genetic dyslipidemias, has launched the Lp(a) AW(a)RE(TM) initiative to engage key U.S. healthcare ...

Please provide your email address to receive an email when new articles are posted on . Lp(a) was linked to increased risk for PAD, major adverse limb events and carotid stenosis. Lp(a) may be a ...

A combined analysis of blood tests to measure three biomarkers linked to higher risk of cardiovascular disease—lipoprotein a ...